Detalhe da pesquisa
1.
Development of a framework and decision tool for the evaluation of health technologies based on surrogate endpoint evidence.
Health Econ
; 31 Suppl 1: 44-72, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35608044
2.
Development, validation and effectiveness of diagnostic prediction tools for colorectal cancer in primary care: a systematic review.
BMC Cancer
; 20(1): 1084, 2020 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33172448
3.
EXPLICIT: a feasibility study of remote expert elicitation in health technology assessment.
BMC Med Inform Decis Mak
; 17(1): 131, 2017 Sep 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28870196
4.
A comparison of two methods for expert elicitation in health technology assessments.
BMC Med Res Methodol
; 16: 85, 2016 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-27456844
5.
Do we know enough about the effect of low-dose computed tomography screening for lung cancer on mortality to act? An updated systematic review, meta-analysis and network meta-analysis of randomised controlled trials 2017 to 2021.
Diagn Progn Res
; 7(1): 26, 2023 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38072977
6.
Coverage with evidence development schemes for medical devices in Europe: characteristics and challenges.
Eur J Health Econ
; 22(8): 1253-1273, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34117987
7.
Validity of Surrogate Endpoints and Their Impact on Coverage Recommendations: A Retrospective Analysis across International Health Technology Assessment Agencies.
Med Decis Making
; 41(4): 439-452, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33719711
8.
Cancer diagnostic tools to aid decision-making in primary care: mixed-methods systematic reviews and cost-effectiveness analysis.
Health Technol Assess
; 24(66): 1-332, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33252328
9.
Surrogate Endpoints in Health Technology Assessment: An International Review of Methodological Guidelines.
Pharmacoeconomics
; 38(10): 1055-1070, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32572825
10.
Informing Reimbursement Decisions Using Cost-Effectiveness Modelling: A Guide to the Process of Generating Elicited Priors to Capture Model Uncertainties.
Pharmacoeconomics
; 35(9): 867-877, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28616775
11.
Methods to elicit probability distributions from experts: a systematic review of reported practice in health technology assessment.
Pharmacoeconomics
; 31(11): 991-1003, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24105473